Search results
19 wrz 2024 · Read the new ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The updated management guidelines aim to: Allow for a more complete and precise estimation of risk; Provide more appropriate intervention for high-risk individuals ; Recommend less intervention for low-risk individuals
- Online Terms and Conditions
American Society for Colposcopy and Cervical Pathology...
- Online Terms and Conditions
The new guidelines provide risk thresholds for clinical action (Table 1) and establish risk estimates for the development of cervical intraepithelial neoplasia grade 3 (CIN 3), adenocarcinoma in situ, or cancer (ie, CIN 3+) for different combinations of test results.
The adoption of the USPSTF guidelines expands the recommended options for cervical cancer screening in average-risk individuals aged 30 years and older to include screening every 5 years with primary high-risk human papillomavirus (hrHPV) testing.
Guidelines Overview. Links and resources related to cervical screening, management, and colposcopy guidelines and recommendations. Screening Guidelines. Screening recommendations for the identification of precursors and prevention of cervical cancer. View Screening Guidelines. Management Guidelines & the Enduring Guidelines Process.
Updated US consensus guidelines for management of cervical screening abnormalities are needed to accommodate the 3 available cervical screening strategies: primary human papillomavirus (HPV) screening, cotesting with HPV testing and cervical cytology, and cer-vical cytology alone.
The ASCCP Cervical Cancer Screening Task Force Endorsement and Opinion on the American Cancer Society Updated Cervical Cancer Screening Guidelines. View Guidelines. Definitions. ASCCP Endorsement. Endorsement of a peer organization’s clinical document denotes that ASCCP fully supports the clinical guidance in the document.
This joint guideline from the American Cancer Society, the American Society for Colposcopy and Cervical Pathology, and the American Society for Clinical Pathology recommends different surveillance strategies and options based on a woman’s age, screening history, other risk factors, and the choice of screening tests.
